HCP_Clinical Efficacy in TBI Patients

Clinical Efficacy in TBI Patients

Somazina has been studied in several clinical trials of TBI patients.

®

Somazina improves memory

®

In a clinical study with 14 patients with mild-to-moderate head injury, treatment with citicoline for one month improved recognition memory .

The above information is for your reference only. It cannot be used in place of a consultation with a medical professional nor as a basis of self-diagnosis or for treatment decision. Only your physician can provide you with accurate diagnosis and appropriate treatment.

References
1. Maldonado VC, Calatayud Pérez JB and Escario JA. Effects of CDP-choline on the recovery of patients with head injury. J Neurol Sci 1991;103 Suppl:S15-S18. 2. Levin HS. Treatment of postconcussional symptoms with CDP-choline. J Neurol Sci 1991;103 Suppl:S39-S42. 3. Secades JJ. Citicoline for the treatment of head injury: A systematic review and meta-analysis of controlled clinical trials. Trauma Treat 2014, 4:1.

Somazina helps give a better chance of making a good recovery

®

Researchers observed that treatment with citicoline helped resume normal occupational and social activities in a clinical trial with 216 patients with moderate-to-severe head injuries .

Somazina helps restore patients’ independence

®

Data analysis of a total of 2,706 TBI patients from 12 clinical trials showed that the use of citicoline was associated with an increased rate of patient independence .